Cornerstone Select Advisors’s Takeda Pharmaceutical TAK Stock Holding History

Cornerstone Select Advisors’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$228K	Buy	14,194 +2,702	+24%	+$44.7K	0.1%	132
2026 Q1	$213K	Sell	11,492 -98	-0.8%	-$1.72K	0.13%	115
2025 Q4	$181K	Buy	11,590 +105	+0.9%	+$1.5K	0.13%	115
2025 Q3	$168K	Hold	11,485	–	–	0.12%	108
2025 Q2	$178K	Hold	11,485	–	–	0.16%	108
2025 Q1	$171K	Sell	11,485 -1,130	-9%	-$15.8K	0.16%	108
2024 Q4	$167K	Buy	+12,615	New	+$173K	0.16%	110

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Cornerstone Select Advisors's TAK Position: Q2 2026 in Review

Cornerstone Select Advisors increased its Takeda Pharmaceutical (TAK) stake by 24% in Q2 2026, buying an estimated $44.7K and bringing the position to 14,194 shares worth $228K. The position accounts for 0.1% of the portfolio, ranked #132.

Cornerstone Select Advisors first reported a position in TAK in Q4 2024 and has held it in 7 quarters since. 378 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

Cornerstone Select Advisors held 14,194 shares of Takeda Pharmaceutical worth $228K as of Q2 2026.
Cornerstone Select Advisors bought 2,702 Takeda Pharmaceutical shares in Q2 2026, an estimated $44.7K.
Takeda Pharmaceutical made up 0.1% of Cornerstone Select Advisors's portfolio in Q2 2026, its #132 holding.
Cornerstone Select Advisors first reported a position in Takeda Pharmaceutical in Q4 2024 and has held it in 7 quarters since.
378 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Cornerstone Select Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.